Fig. 3From: Actual versus ideal body weight dosing of sugammadex in morbidly obese patients offers faster reversal of rocuronium- or vecuronium-induced deep or moderate neuromuscular block: a randomized clinical trialRecovery time to TOF ratio ≥ 0.9 for subgroups. Point estimates and 95% CI presented for respective pooled ABW and IBW groupsBack to article page